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Summary
Chemokine-dependent migration of T lymphocytes assures recir-
culation of naı¨ve T cells to secondary lymphoid organs and tissue-
specific trafficking of memory-effector T cells. Previous studies
carried out in rodents have demonstrated age-associated modula-
tion of the expression of chemokine receptors such as CXCR4 and
CCR5; however, little is known about the molecular mechanisms
that regulate receptor expression and turnover in T cells, during
advancing age in humans. Our recent results demonstrating
increased chemotactic migration in response to CXCL12 in CD4+
T cells obtained from the elderly, as compared to those from
young donors, led us to hypothesize that increase in surface
expression, because of altered endocytic regulation of CXCR4 on T
cells during aging, might be directly responsible for increased
migration toward CXCL12. Studies presented here demonstrate a
significant increase in the surface expression of CXCR4 in CD4+
T cells from elderly human donors, relative to those from the
young. Additionally, CXCL12-mediated endocytosis of CXCR4 was
differentially regulated during aging, which could be attributed
to alterations in the ubiquitination of CXCR4. Thus, altered ubiqui-
tination of CXCR4 may contribute to the increased surface expres-
sion and enhanced T-cell migration to chemotactic stimuli in the
elderly.
Key words: aging; human; signal transduction; T cell; ubiqui-
tin pathway; CXCR4.
Introduction
Studies have well documented that aging significantly attenuates the
ability of an individual to mount appropriate immune responses (Arnold
et al., 2011; Baum et al., 2011; Ponnappan & Ponnappan, 2011). Most
of the studies dealing with immunity during advancing age in humans
have focused on the impact of age on antigen-specific TCR-repertoire
diversity, antigenic reactivity, and T-cell-dependent antibody generation
in response to vaccination (Caruso et al., 2005; Brunner et al., 2011;
Deeks, 2011; den Elzen et al., 2011), with only a limited number focusing
on trafficking and ⁄ or chemotactic migration. Studies in murine models of
aging that have reported on chemotactic migration, demonstrate a signif-
icantly higher response to the chemokine CXCL12 in T cells from aged
mice than those from younger cohorts (Steeber et al., 1996; Stohlawetz
et al., 1996; Toichi et al., 1997; Nyugen et al., 2010). As migration and
trafficking of memory and naı¨ve T cells are critical to mounting an effec-
tive immune response, any defect in these properties is likely to negatively
impact this ability. Therefore, understanding the impact of aging on
chemokines and chemokine receptors in regulating migration is essential
to delineating immune senescence.
Chemokines and chemokine receptors have been shown to exquisitely
regulate T-cell migration (Estes et al., 2004; Contento et al., 2008; Bai
et al., 2009; Booth et al., 2010; Bunting et al., 2011). Among these
receptors, CXCR4, a member of the G protein-coupled receptor (GPCR)
family, has received a great deal of attention because of its vital role in
T lymphocyte development, migration and cytokine secretion. The func-
tions attributed to CXCR4 in T lymphocytes are linked to its surface
expression, which is regulated by ligand-dependent endocytosis and deg-
radation of the endocytosed receptor. Abnormal expression or function
of CXCR4 has been reported in several diseases such as cancer, cardiovas-
cular disease, inflammatory allergic disease, HIV, and neuroinflammatory
disease (Feng et al., 1996; Abu El-Asrar et al., 2001; Rauer et al., 2002;
Burger et al., 2003; Walter et al., 2005). Ligand-dependent stimulation
of CXCR4 has been demonstrated to result in endocytosis and degrada-
tion, following ubiquitination and lysosomal targeting. Three sites for
ubiquitination have been identified on CXCR4 that are linked to lysosomal
degradation (Marchese & Benovic, 2001; Marchese et al., 2003; Bhandari
et al., 2007, 2009; Malik & Marchese, 2010; Caballero & Marchese,
2011). Interestingly, mono-ubiquitination of CXCR4 is not required for
endocytosis and trafficking, but is essential for receptor degradation.
Agonist-mediated activation appears to promote mono-ubiquitination
and lysosomal degradation of CXCR4 in HEK293 cell line via a mechanism
dependent on ubiquitin ligase, AIP4, (Marchese et al., 2003; Bhandari
et al., 2009). Indeed, activation of CXCR4 in HEK293 cells expressing cat-
alytically inactive AIP4 mutants or depleted of AIP4 by siRNA, results in
reduction, but not complete abrogation of ubiquitination and degrada-
tion. This partial inhibition of mono-ubiquitination and degradation
allowed us to posit that other mechanisms, perhaps poly-ubiquitination
by alternative ligases and proteasome-mediated degradation, may also be
involved in CXCR4 regulation during aging (Lapham et al., 2002; Mar-
chese, 2009; Berlin et al., 2010). Support for this hypothesis is based on
studies in which pretreatment with lactacystin, a cell-permeable protea-
some-specific inhibitor, increased the surface expression of CXCR4 in
T lymphocytes. Therefore, it is likely that CXCL12-induced CXCR4
internalization and ⁄ or degradation involves multiple lysine-dependent
mono-ubiquitination or poly-ubiquitination events. Additionally, deubiq-
uitination events, primarily attributed to USP14, appear to be critical in
controlling ligand-dependent CXCR4 internalization, degradation, and
chemotaxis. While it was reported that over-expression of USP14
followed by CXCL12 treatment resulted in a significant reduction in
CXCR4-dependent migration (Mines et al., 2009), little is known about
the impact of USP14 inhibition on CXCR4 surface expression in T cells in
general and specifically during aging. We now report that age-associated
alteration in the expression of CXCR4 in T cells from the elderly appears to
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underlie increased migration observed in response to CXCL12. Employing
a small molecule inhibitor of USP14 and analysis of ubiquitination of
CXCR4, we now demonstrate age-associated alteration in the ubiquitina-
tion status of CXCR4, which may directly or indirectly regulate the expres-
sion and ⁄ or internalization of the receptor.
Results
CD4+ T cells demonstrate increased surface expression of
CXCR4 during aging.
As our previous studies clearly demonstrated that CD4+ T cells from the
elderly have higher migratory index in response to CXCL12 (Cane et al.,
2012), we next evaluated the surface expression of CXCR4 in CD4+ T cells
obtained from both young and elderly donors. Expression of CXCR4 was
analyzed in primary human CD4+ T cells, as well as in CD4+ CD45RO+
and RA+ T-cell subsets, because aging is often accompanied by a shift in
population of CD4+ naı¨ve T cells to a predominantly CD4+ memory T-cell
subset.
As shown in Fig. 1A,B, S1, levels of both the surface as well as intracel-
lular expression of CXCR4 appeared to be higher in CD4+ T cells obtained
from elderly donors as compared to those from the young. Further, as
shown in Fig. 1C, CD4+ CD45RA+ naı¨ve T-cell subset appeared to have
higher levels of surface expression of CXCR4 relative to CD4+ CD45RO+
memory subset, derived from both young and elderly donors. Addition-
ally, irrespective of the age of the donor, intracellular levels of CXCR4
were far greater than those detected on the surface of T cells. To deter-
mine whether the observed increase in CXCR4 expression in T cells from
the elderly correlated with an overall increase in CXCR4 protein and ⁄ or
mRNA expression, we next assessed the protein and mRNA levels of
(D)
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Fig. 1 Increased surface expression of CXCR4 in CD4+ T cells during aging. (A). Left panel: Surface expression of CXCR4 in CD4+ T cells from young and elderly donors. CD4+
T cells obtained from young and elderly donors were labeled using antibody to CXCR4, followed by Alexa Fluor 488-conjugated secondary antibody staining and then fixed
with 2% PFA. Right panel: Intracellular expression of CXCR4 in CD4+ T cells obtained from young and elderly donors. CD4+ T cells obtained from young and elderly donors
were fixed using 2% PFA and then permeabilized with 1xPBS buffer containing 0.1% Saponin. Cells were then stained using an antibody to CXCR4, followed by Alexa Fluor
488-conjugated secondary antibody. Cell surface and intracellular expression of CXCR4 were detected by flow cytometry. Cumulative data of percent cells expressing CXCR4
obtained from 10 independent donor pairs are provided. **Denotes statistical significance at P < 0.001. (B). Flow cytometry of CD4+ T cells from young and elderly donors
stained for intracellular and extracellular CXCR4 expression, using antibody to CXCR4, followed by secondary antibody coupled to fluorochrome. Representative data from
one young (Left panel)) and elderly (Right panel) donor pair are provided. Intracellular CXCR4 staining was carried out using fixed, permeabilized CD4+ T cells, while
extracellular staining was carried out on unfixed cells. Isotype stained cells served as negative controls. MFI indicates mean fluorescence intensity. (C). Surface and intracellular
expression of CXCR4 in CD4+ CD45RO+ and RA+ T-cell subsets from young and elderly donors. Cumulative data of percent cells expressing CXCR4 obtained from 10
independent donor pairs are provided. (D). Increased levels of CXCR4 in CD4+ T cells from the elderly. A representative western blot of CXCR4 in CD4+ T-cell lysates obtained
from young and elderly donors are provided. b-actin was used as a protein loading control. Representative data from one donor pair out of 10 pairs tested are provided.
(E). Quantitation of the specific band corresponding to CXCR4 protein was carried out by densitometry. Values represent mean integrated density ± SE obtained from 10
independent donor pairs. **Denotes statistical significance at P < 0.001. (F). qRT-PCR analysis of CXCR4 mRNA from total RNA isolated from CD4+ T cells obtained from
young and elderly donors. Data obtained from 10 donor pairs are provided. b-actin and GAPDH were used as reference genes and for normalization. Data are presented as
fold induction.
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CXCR4, in CD4+ T cells obtained from young and elderly donors. As
shown in Fig. 1D,E, total CXCR4 levels in CD4+ T cells from elderly donors
were significantly higher relative to those from young donors. Examina-
tion of mRNA expression of CXCR4 employing qRT-PCR in CD4+ T cells,
shown in Fig. 1F, demonstrate similar levels of CXCR4 mRNA in CD4+
T cells from both young and elderly donors.
Minimal impact of aging on the surface expression of
CCR5 in resting and activated CD4+ T cells
To evaluate whether the increase in expression of CXCR4 observed in
CD4+ T cells from elderly donors was exclusive to this chemokine receptor
and not to a generalized increase in the surface expression of all chemoki-
ne receptors during aging, we next assessed the expression of CCR5.
CCR5 was chosen for the study because it has been demonstrated to be
constitutively expressed in T lymphocytes and has been shown to syner-
gize with CXCR4 in controlling the migration of CD14+ monocytes and
CD3+ T cells (Desmetz et al., 2007; Contento et al., 2008; Gouwy et al.,
2011). Additionally, CCR5 has also been reported to increase and sustain
CXCR4 ligand-induced ERK phosphorylation and activation, necessary for
gene transcription and cytokine production in response to CXCL12 (Yopp
et al., 2004; Gouwy et al., 2011). As shown in Fig. 2A,B, surface expres-
sion of CCR5 showed a consistent but minimal increase between both
the age groups, under resting and as well as under activated (PMA +
Ionomycin) conditions. As CCR5 is known to regulate chemotactic migra-
tion in T cells, we next examined the effect of different concentrations of
CCL8, ligand for CCR5, on CD4+ T-cell migration using a trans-well assay.
As shown in Fig. 2C, a dose-dependent increase in migration was
observed in CD4+ T cells obtained from both young and elderly donor
groups, with the dose of 10 nM of CCL8 eliciting the maximum migration
index. Thus, employing CCL8 at 10 nM, we next assessed the migration
of CD4+ T cells from both young and elderly donors. As shown in Fig. 2D,
CD4+ T cells obtained from both young and elderly donors migrated
toward CCL8, showing little impact of age on migration. In CD4+ T cells
that were pretreated with PMA + Ionomycin, the migration index
increased, demonstrating a direct correlation with increased cell surface
expression of CCR5. Interestingly, unlike our results obtained in response
to CXCL12, the age of the CD4+ T-cell donor had little impact on the abil-
ity of CD4+ T cells to migrate toward CCL8. Thus, a specific increase in
the surface expression of CXCR4, and not a generalized increase in over-
all expression of chemokine receptors, is attributable to the increase in
CXCL12-dependent migration observed in T cells from the elderly.
Differential ubiquitination of CXCR4 occurs in CD4+
T cells during aging and may contribute to
increased surface expression
To understand the molecular mechanism ⁄ s that contributes to the
observed increase in CXCR4 surface expression in CD4+ T cells from
elderly donors, we next evaluated the stability of CXCR4 expression
during aging. In fact, as previous studies have demonstrated that ubiqui-
tination at the C-terminal domain of CXCR4 is required for lysosome-
mediated receptor degradation, we focused on ubiquitination of CXCR4
(Marchese & Benovic, 2001; Bhandari et al., 2007; Malik & Marchese,
2010; Caballero & Marchese, 2011). Additionally, previous studies have
also shown that ligand-induced stimulation of CXCR4 results in increased
(A) (B)
(C) (D)
Fig. 2 CCR5 surface expression in resting and activated CD4+ T cells during aging. (A & B). Surface expression of CCR5 in CD4+ T cells from young and elderly donors. CD4+ T
cells obtained from young and elderly donors were either left untreated (A) or activated with PMA ⁄ Ionomycin for 12 h (B), stained using antibody to CCR5 followed by Alexa
Fluor 555-conjugated secondary antibody. Surface expression of CCR5 was detected by flow cytometry. Cumulative data obtained from a minimum of 8 independent donor
pairs are provided. **Denotes statistical significance at P < 0.001; **Denotes statistical significance at P < 0.009. (C). Dose-dependent migration of CD4+ T cells from young
and elderly donors to CCL8 gradient. CD4+ T cells (3 · 105) from young and elderly donors were placed in the upper chamber of a trans-well migration plate (5 lM pore) and
allowed to migrate for 4 h at 37C toward a gradient generated by either 1, 10, 50 or 100 nM of CCL8. The number of migrating cells present in the lower chamber was
assessed by Trypan Blue staining, and the percentage of migrating cells is provided. Values represent mean ± SE from four independent donor pairs. (D). Chemotactic
migration of CD4+ T cells from young and elderly donors to CCL8 gradient. CD4+ T cells were either left untreated or pretreated with PMA ⁄ Ionomycin for 12 h. Data are
representative of 10 independent donor pairs and represent percentage of migrating CD4+ T cells from young and elderly donors in response to CCL8.
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ubiquitination, mediated by a complex formed by E3 ubiquitin ligase
AIP4, underscoring the importance of ubiquitination (Marchese et al.,
2003; Bhandari et al., 2009). As shown in Fig. 3A,B, immuno-precipita-
tion of CXCR4 followed by western blot with antibody to CXCR4 demon-
strated several CXCR4 isoforms in CD4+ T-cell lysates from both young
and elderly donors (3A, long exposure). The appearance of several
isoforms of CXCR4 (antibody reactive bands) is in agreement with obser-
vations made in other cell types. Interestingly, CXCR4 isoforms at 45, 62
and 100 kDa, appear to be lower in the immunoprecipitates of lysates
derived from CD4+ T cells obtained from the elderly relative to those from
the young. In contrast, the isoform ⁄ s appearing above 150 kDa is more
abundant in the elderly relative to that seen in immunoprecipitates from
the young. As the appearance of these isoforms may be attributable to
differential ubiquitination of CXCR4, we next tested the lysates for ubiqu-
itin-dependent modification of CXCR4, following immunoprecipitation
with anti-CXCR4. As seen in Fig. 3B, CXCR4 is indeed differentially ubiq-
uitinated in lysates obtained from the young, relative to those from the
elderly (3B, long exposure). Additionally, the presence of heavily poly-
ubiquitinated CXCR4 in the immunoprecipitates from the elderly, appear-
ing at > 150 kDa molecular weight, but not from the young, suggests
the involvement of the proteasome in the accumulation, and perhaps in
down-regulating, CXCR4 molecules. As our laboratory has previously
reported age-associated deficits in proteasomal catalytic function in
T cells from the elderly (Das et al., 2007; Ponnappan et al., 2007;
Ponnappan & Ponnappan, 2011), accumulation of high molecular weight
polyubiquitinated-CXCR4 may be an outcome of such a defect. This
observation is further supported by independent reports that employed
chemical inhibition of the proteasome, resulting in increased surface
expression of CXCR4 in lymphocytes. Thus, results presented here dem-
onstrate that alterations in the ubiquitination of CXCR4 and ⁄ or protea-
some function may account for the increased surface expression of
CXCR4 observed in CD4+ T cells during aging.
Inhibition of USP14 results in increased surface expression
of CXCR4
As previous experiments indicated increased polyubiquitinated CXCR4
isoforms occurring in CD4+ T cells from the elderly, implying alteration in
the ubquitination ⁄ deubiquitination cycle of CXCR4, we next evaluated
the effect of inhibition of a deubiquitinating enzyme, USP14, on the sur-
face expression of CXCR4. We chose to target USP14, because previous
studies have reported a critical role for USP14 in CXCR4 degradation and
chemotaxis mediated by CXCL12 (Mines et al., 2009). CD4+ T cells from
young and elderly donors were either left untreated or pretreated with a
small molecule inhibitor of USP14, IU-1, and then activated with CXCL12.
At the end of the treatment, surface expression of CXCR4 was evaluated
by flow cytometry employing a CXCR4-specific antibody. As shown in
Fig. 4, increase in the surface expression of CXCR4 upon IU-1 treatment
occurred in CD4+ T cells obtained from both young and elderly donors,
suggesting that USP14-specific deubiquitination activity is essential for
CXCR4 internalization. Interestingly, we also observed that pretreatment
with IU-1 partially blocked CXCL12-mediated CXCR4 down-modula-
tion ⁄ degradation in CD4+ T cells from young donors but not in those
from the elderly, indicating an age-associated defect in ligand-induced
degradation of CXCR4 in CD4+ T cells. Thus, inhibition of USP14 results in
increased surface expression of CXCR4 and negatively impacts CXCL12
mediated CXCR4 internalization and degradation, by regulating the ubiq-
uitination ⁄ deubiquitination cycle.
Decreased ligand-induced degradation of CXCR4 in CD4+ T
cells during aging
Upon stimulation with CXCL12, CXCR4 is internalized and sorted through
the endosomal compartment, where it is either recycled back to plasma
membrane or is degraded. The observed decrease in mono-ubiquitination
(A)
(B)
Fig. 3 CXCR4 is differentially ubiquitinated in CD4+ T cells during aging.
(A). Lowered expression of low molecular weight CXCR4 isoforms in CD4+ T cells
from the elderly. CD4+ T-cell lysates obtained from a pool of 5 young and 5 elderly
donors were immunoprecipitated with an antibody to CXCR4. The
immunoprecipitate was resolved using SDS-PAGE and detected using an antibody
to CXCR4. Representative blot from one immune-precipitation assay is provided.
Arrows depict approximate molecular weight of the CXCR4 isoforms derived from
molecular weight standards, and approximate number of ubiquitin tags that could
account for the increase in molecular weight. (B). Decreased monoubiquitination
and increased polyubiquitination (>8Ub-linkages) of CXCR4 in CD4+ T cells,
accompanies aging. Cell lysates of CD4+ T cells obtained from 3 independent pools
of 5, 3, and 3 young and elderly donors were immunoprecipitated with an antibody
to CXCR4. Resolved immunoprecipitates were immunoblotted with antibody to
ubiquitin. Long exposure indicates extended exposure of the film to demonstrate
the appearance of intense high molecular weight CXCR4 isoforms denoting
polyubiquitination. Arrows indicate ubiquitinated species attributable to 1, 3, and 8
ubiquitin linkages and are based on approximately 8.5 kDa increments in molecular
weight.
Regulation of CXCR4 expression during aging, S. Cane´ et al.
ª 2012 The Authors
Aging Cell ª 2012 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
654
of CXCR4 in resting CD4+ T cells obtained from the elderly donors,
prompted us to evaluate whether CXCL12-dependent degradation of
CXCR4 was also impaired in CD4+ T cells from the elderly. CD4+ T cells
obtained from both young and elderly donors were either left untreated
or activated with CXCL12 (100 nM) for 1 and 3 h. As shown in Fig. 5A,B,
we observed a time-dependent decrease in CXCR4 levels in the lysates of
CD4+ T cells obtained from young donors, but not in those from the
elderly, where the levels of CXCR4 appeared to be minimally affected,
irrespective of the length of activation with CXCL12. Thus, our results
suggest that ligand-dependent CXCR4 degradation is impaired in CD4+
T cells from elderly donors.
Discussion
Chemokine-dependent migration is a fundamental feature of T-cell func-
tion that ensures homing of naı¨ve T cells to secondary lymphoid organs
and recirculation of memory-effector T cells to the periphery (Friedman
et al., 2005; Contento et al., 2008; Bunting et al., 2011). CXCL12 and its
receptor CXCR4 have garnered a great deal of interest because of their
central role in inflammation, homeostasis, migration in the immune sys-
tem, and in a wide variety of cancers because of their increased associa-
tion with cancer progression and tumor cell proliferation (Zlotnik et al.,
2011). Additionally, the recognition of CXCR4 as a co-receptor for HIV
infection has provided greater significance for its expression within T-cell
subsets (Feng et al., 1996). Recent studies on WHIM syndrome, a con-
genital immune deficiency, have demonstrated mutations of the intracel-
lular carboxy terminus of CXCR4. WHIM leukocytes have enhanced
responses to CXCL12 because of receptor desensitization (Bachelerie,
2010). Thus, any biological process that alters the level and ⁄ or function
of chemokine receptors will likely impact the ability of the immune sys-
tem, not only to mount appropriate responses to invading pathogens,
but also to affect immune homeostasis.
Limited information regarding changes of chemokine receptors during
human aging, coupled together with our previous observation of
increased chemotactic migration toward CXCL12 gradient in CD4+ T cells
from the elderly, prompted us to evaluate the expression, function and
regulation of CXCR4 in CD4+ T cells from young and elderly donors. Here,
we provide evidence that CD4+ T cells from the elderly have increased
surface expression of CXCR4, which may partly contribute to the
increased migration toward a gradient generated by CXCL12, previously
described by our laboratory (Cane et al., 2012). While the overall protein
levels of CXCR4 are also significantly increased in CD4+ T cells during
aging, the mRNA levels remain unaffected, suggesting a role for post-
translational regulation. Our results of increased CXCR4 expression is in
partial agreement with previously published results by Yung and
colleagues in a murine model of aging employing splenic lymphocytes
(Mo et al., 2003). To determine whether a generalized up-regulation of
chemokine receptor expression accompanies aging, we next evaluated
CCR5 expression. Interestingly, we found that, unlike CXCR4, surface
expression of CCR5 on CD4+ T cells showed only a minimal increase in
cells from the elderly, both under resting conditions, as well as upon acti-
vation with PMA ⁄ Ionomycin. Thus, the expression of CXCR4 to a greater
extent and CCR5 to a lesser extent was affected by advancing age. As
cells exposed to a chemotactic gradient generated by CXCL12 demon-
strated increased migratory index in T cells from the elderly, we next
assessed migration of T cells toward CCL8, the ligand for CCR5. In a che-
motactic gradient generated by CCL8, CD4+ T cells obtained from both
young and elderly donors demonstrated similar migratory indices in a
Fig. 4 Inhibition of USP14 results in increased CXCR4 surface expression in CD4+ T
cells. Surface expression of CXCR4 in CD4+ T cells from young and elderly donors.
CD4+ T cells obtained from young and elderly donors were either left untreated or
pretreated with IU-1 (50 lM; 4 h), and then either activated with CXCL12 (100 nM;
1 h), or not. T cells were then stained using an antibody to CXCR4, followed by
Alexa Fluor 488-conjugated secondary antibody. Surface expression of CXCR4 was
detected by flow cytometry. Data obtained from three independent donor pairs are
provided. **Denotes statistical significance at P < 0.007; *Denotes statistical
significance at P < 0.02.
(A)
(B)
Fig. 5 Decreased ligand-induced degradation of CXCR4 in CD4+ T cells
accompanies aging. (A). Representative western blot of the predominant CXCR4
isoforms in CD4+ T-cell lysates obtained from young and elderly donors that were
either left untreated or treated with CXCL12 for 1 and 3 h. b-actin was used as a
control for equal protein loading. (B). Percent degradation of CXCR4 following
CXCL12 treatment at 1 and 3 h relative to control (untreated) obtained from young
and elderly donors are presented. Values represent mean ± SE obtained from a
minimum of 6 independent donor pairs. **Denotes statistical significance at
P < 0.003; *Denotes statistical significance at P < 0.05.
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trans-well assay, suggesting that the minimal change in CCR5 expression
did not significantly impact migration toward CCL8. These results led us
to conclude that the increase in CXCR4 expression with age is not due to
a generalized age-associated increase in chemokine receptor expression
and function, but rather to a specific increase in CXCR4.
Although, it appears that CXCR4 regulation is altered during aging, the
molecular mechanism ⁄ s dictating this change in CXCR4 remains to be
fully defined. In keeping with previous reports (Zaitseva et al., 1998;
Contento et al., 2008), our studies in CD4+ T cells obtained from human
donors demonstrate the occurrence of different isoforms of CXCR4,
based on cross-reactivity with an antibody specific to CXCR4. Our results
for the first time demonstrate an age-associated effect on the nature of
the detected CXCR4 isoforms. It appears that CXCR4 isoforms with high
molecular weights are more abundant in lysates derived from CD4+ T cells
from the elderly relative to those from the young. However, it should be
noted that not all high molecular weight isoforms are consistently
observed in samples from the elderly. The ‘‘ladder-like’’ high molecular
weight bands observed in the elderly suggested that they might corre-
spond to polyubiquitinated forms of CXCR4. As several studies have
shown ubiquitination of CXCR4 on lysine residues located at the C-termi-
nal domain of CXCR4 by the E3 ubiquitin ligase AIP4 is responsible for tar-
geting it to lysosome for degradation, such a modification seemed like a
plausible explanation for the occurrence of high molecular weight iso-
forms (Marchese et al., 2003; Bhandari et al., 2009; Caballero & Mar-
chese, 2011). Indeed, in agreement with previous reports, we now
demonstrate that in CD4+ T cells from young donors, several CXCR4 iso-
forms are differentially ubiquitinated, with fewer polyubiquitinated iso-
forms. In contrast, relatively higher levels of polyubiquitinated CXCR4
isoforms are observed in CD4+ T cells from the elderly, lending support to
our hypothesis. Although, at this time, it is technically challenging to
experimentally discriminate between polyubiquitinated or multiply-
monoubiquitinated CXCR4 isoforms, and whether they exhibit K-48 and
K-63 ubiquitin linkages, future studies will attempt to address these
issues. One probable underlying basis for the increase in polyubiquitinat-
ed species of CXCR4 in T cells from the elderly may be attributable to the
altered intracellular redox potential in CD4+ T cells during aging coupled
with proteasomal dysfunction (Ponnappan et al., 2007; Ponnappan &
Ponnappan, 2011). This increased polyubiquitinated species may confer
stability, resulting in increased surface expression, leading to higher che-
motactic migratory index toward CXCL12 gradient. Additionally, our
findings of altered kinetics of ligand-mediated degradation of CXCR4 in
CD4+ T cells from the elderly, strongly support the contention that mech-
anisms involved in CXCR4 down-modulation may also be altered during
aging. Our studies for the first time unravel a role for the deubiqitinating
enzyme USP14, in the ubiquitination ⁄ deubiquitination cycle of CXCR4.
These studies further point to an age-associated alteration of the regula-
tion of USP14. Previous reports of USP14 regulation have implicated both
inhibition and over-expression of USP14 in increased surface expression
of CXCR4 (Mines et al., 2009). In keeping with this observation, our stud-
ies demonstrate that treatment with a small molecule inhibitor of USP14,
IU1, results in a significant increase in CXCR4 levels in CD4+ T cells, irre-
spective of the donor age. Interestingly, increased levels of USP14 are
observed in cells from the elderly, relative to those from young donors
(data not shown). We believe that this inherent increase in USP14 in
T cells may underlie increased CXCR4 expression observed in the elderly.
However, it should be noted that the experiments designed in this study
fail to discriminate whether USP14-mediated regulation of CXCR4
expression is either direct or indirect.
In summary, the observations that emerge from these studies begin to
shed light on the underlying basis for the increase in migration observed
in CD4+ T cells during aging by primarily focusing on CXCR4 regulation.
The increased expression and altered post-translational ubiquitination of
CXCR4 in CD4+ T cells from the elderly, coupled with altered USP14 activ-
ity, may result in the retention of CXCR4 on the surface and thus contrib-
ute to increased migration toward a chemotactic gradient generated by
CXCL12. Given the roles of redox regulation, proteasome and ubiquitina-
tion in CXCR4 regulation, further investigations are clearly warranted to
dissect the relationships involving these pathways in the context of aging
and immune senescence.
Experimental procedures
Antibodies and reagents
Horseradish peroxidase-conjugated goat anti-mouse antibody was from
BD Biosciences (San Jose, CA, USA). Antibodies to human CCR5, CD4
CD45-RO, and CD4 CD45-RA were from eBiosciences (San Diego, CA).
Antibody to b-actin and CXCR4 were from Santa Cruz biotechnology
(Santa Cruz, CA, USA). Alexa Fluor 555-conjugated goat anti-mouse sec-
ondary antibody and Alexa Fluor 488-conjugated goat anti-rabbit sec-
ondary antibody were from Invitrogen (Carlsbad, CA, USA). Antibody to
ubiquitin-protein conjugates was from Enzo Life Sciences (Farmingdale,
NY, USA). Horseradish peroxidase-conjugated goat anti-rabbit antibody
was from Thermo Scientific (Rockford, IL, USA). All fine chemicals, unless
otherwise mentioned, were obtained from Sigma-Aldrich (St. Louis, MO,
USA). CXCL12 and CCL8 were from ProSpec-Tany Technogene (Rehovot,
Israel). Electrophoresis supplies were from Bio-Rad (Hercules, CA, USA).
USP14 small molecule inhibitor (IU1) was from BioVision (Mountain View,
CA, USA).
Human subjects
Peripheral blood was obtained by venipuncture from healthy young (21–
30 years) and elderly (65–89 years) adults enrolled from the greater Little
Rock area. Immuno-compromised subjects were excluded, including indi-
viduals with asthma and those taking immune-modulating drugs upon
consultation with the study geriatrician. Subjects on antibiotics or who
self-reported symptoms of recent infection (<3 weeks before enrollment)
were excluded. All protocols involving human subjects were approved by
the UAMS Institutional Review Board and appropriate informed consents
were obtained. Blood draw was performed at the Clinical Research Cen-
ter (CRC) at UAMS.
T lymphocyte isolation
CD4+ T cells were negatively selected from blood using the EasySep CD4+
T-cell enrichment kit per manufacturer’s recommended protocol (Stem-
Cell Tech., Vancouver, Canada). Purity of isolated CD4+ T cells was deter-
mined by flow cytometry and was consistently found to be 90–95% pure.
CD4+ CD45RO+ and CD4+ CD45RA+ T cells were negatively selected from
blood using EasySep Human Memory CD4+ T-cell enrichment kit and
EasySep Human Naı¨ve CD4+ T-cell enrichment kit, respectively, with
minor modifications of the manufacturer’s recommended protocol (Stem
Cell Tech., Vancouver, Canada). Isolated CD4+CD45RO+ ⁄ RA+ T cells were
determined to be 90–95% pure by flow cytometry.
Western blotting and Immunoprecipitation
CD4+ T-cell lysates, equalized for protein levels, were resolved using
sodium dodecyl sulfate-Polyacrylamide gel electrophoresis (SDS-PAGE),
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transferred to nitrocellulose membrane, immunoblotted with specific
antibody and detected using enhanced chemiluminescence.
For immunoprecipitation studies, precleared cell lysates (200 lg pro-
tein) were incubated with antibody to CXCR4 and protein A ⁄G agarose
beads overnight at 4C with gentle rocking. Protein A ⁄G beads contain-
ing the adsorbed immunoprecipitated complex were washed with RIPA
buffer, resuspended in 30 lL of 2X SDS-sample buffer and heated in a
boiling water-bath for 5 min. Protein complexes were resolved by SDS-
PAGE and subjected to western blot analyses, as detailed previously.
Reverse transcriptase–quantitative polymerase chain
reaction (RT–qPCR)
Total RNA was isolated using TRIzol Reagent (Invitrogen, Carlsbad, CA,
USA). Four microgram of total RNA for each sample was reverse-tran-
scribed and the resultant cDNA was amplified using the Bio-Rad iCycler
PCR system. Reactions were performed in 96-well PCR plates using
12.5 lL of iQ SYBR Green Supermix (Bio-Rad), forward and reverse prim-
ers (0.3 nmol each), and cDNA (3 lL) in a final volume of 25 lL. Amplifi-
cation parameters were denaturation at 95 C for 10 min followed by 40
cycles at 95 C for 30 s and 60 C for 70 s. Samples were analyzed in
duplicate for the expression levels of cxcr4. Housekeeping genes, human
b-actin and GAPDH, were used for normalization. Fold induction was cal-
culated after normalization using the DDCT method. Dissociation curves
indicated that each reaction consisted of a single reaction product. Gene-
specific primers were designed by Primer3 software employing human
sequences obtained from GenBank. Primer sequences will be provided
upon request.
Flow cytometry
For surface staining, CD4+ T cells as well as CD4+ CD45RO+ and RA+
T-cell subsets were either incubated with antibody to CXCR4 or CCR5
followed by incubation with an antibody conjugated to Alexa Fluor-488
or Alexa Fluor-555, respectively, for 20 min at 4C. At the end of incuba-
tion, cells were washed with ice cold PBS containing 0.1% BSA and fixed
with 2% paraformaldehyde (PFA).
Chemotactic migration assay
CD4+ T cells (3 · 105) either untreated or pretreated with PMA
(100 ng ⁄ml) and Ionomycin (500 nM) for 12 h were resuspended in
100 ll of media containing 0.2% BSA and placed into the upper chamber
of a trans-well migration plate (5 lm pore, Costar). In the lower chamber,
600 ll of media containing 0.2% BSA, with or without 10 nM of CCL8,
was added and cells were allowed to migrate for 4 h at 37C. The number
of migrated cells was counted following Trypan Blue staining. For dose-
response experiments, CD4+ T cells (3 · 105) were resuspended in 100 lL
of media containing 0.2% BSA and placed into the upper chamber of a
trans-well migration plate (5 lm pore, Costar). In the lower chamber,
600 lL of media containing 0.2% BSA with 1, 10, 50, or 100 nM of CCL8
was added and cells were allowed to migrate for 4 h at 37C. The number
of migrated cells was counted following Trypan Blue staining.
Assessment of CXCR4 regulation by ligand and
a ubiquitin specific protease inhibitor
To determine ligand-induced degradation of CXCR4, freshly isolated
CD4+ T cells from both young and elderly donors were incubated either
in the presence or absence of CXCL12 (100 nM) for 1 and 3 h. At the end
of incubation, the cells were washed twice with cold 1X PBS and cellular
lysates were obtained. Percent degradation relative to control is
presented.
To evaluate the impact of USP14 inhibition on CXCR4 protein levels,
CD4+ T cells from young and elderly donors were pretreated with IU-1,
50 lM for 4 h, followed by activation with CXCL12 (100 nM) for 1 h. At
the end of the incubation, CD4+ T cells were washed twice with cold
0.1% BSA ⁄ PBS and stained with a CXCR4-specific antibody to assess the
surface expression of CXCR4.
Statistical analyses
Differences between means of the data generated in the study were ana-
lyzed using Student’s t-test. Differences were considered significant, if
P < 0.05.
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